This review highlights key issues and recent progress in understanding the epidemiology, phenomenology, etiology, and treatment of anhedonia in schizophrenia. A reduced pleasure capacity has been recognized as an important feature of the illness since the time of Kraepelin and Bleuler. However, it remains poorly understood for many reasons, including the phenotypic heterogeneity of schizophrenia, the multidimensionality and multifactorial etiology of anhedonia, and the dif-ficulties inherent in the scientific analysis of subjective emotional experiences. We do know that anhedonia is common in schizophrenia, that it has significant negative consequences, and that current treatments are insuf-ficient. Better assessment tools, greater understanding of biological and psychosocial mechanisms, and novel pharmacologic and psychosocial interventions are sorely needed. Anhedonia has received increasing attention in recent years, and there is optimism that the new Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative on negative symptoms will catalyze rapid progress in the near future.
KeywordsSchizophrenia Negative Symptom Schizophrenia Patient Positive Symptom Mesolimbic System
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Ribot TH: The Psychology of Emotions. London: Scott; 1897.Google Scholar
- 3.Kraepelin E: Dementia Praecox and Paraphrenia. Translated by Barclay RM. Huntington, NY: Krieger; 1971 (1919).Google Scholar
- 4.Bleuler E: Dementia Praecox or the Group of Schizophrenias. Translated by Zinkin J. New York: International Universities Press; 1950 (1911).Google Scholar
- 6.Horan WP, Kring AM, Blanchard JJ: Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 2006, 32:259–273. An excellent review of conceptual and methodological issues relevant to assessing anhedonia in schizophrenia. Existing measures are described and their strengths and limitations discussed.PubMedCrossRefGoogle Scholar
- 13.Herbener ES, Harrow M, Hill SK: Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophr Res 2005, 75:97–105. A unique long-term, multi-follow-up study of anhedonia in schizophrenia that found that a trait measure of physical anhedonia is stable over time but becomes increasingly associated with functional impairments. Together with Milev et al. , it highlights the functional impact of negative symptoms throughout the course of illness.PubMedCrossRefGoogle Scholar
- 15.Kirkpatrick B, Fenton WS, Carpenter WT, Jr, et al.: The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006, 32:214–219. Summarizes the conclusions of the recent NIMH consensus development conference on negative symptoms. The committee has created a roadmap for developing methods to assess negative symptoms and conduct clinical trials targeting this domain; this will have a significant impact on the future course of pharmaceutical and academic research programs.PubMedCrossRefGoogle Scholar
- 19.Horan WP, Green MF, Kring AM, et al.: Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol 2006, In press.Google Scholar
- 20.Rector NA, Beck AT, Stolar N: The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry 2005, 50:247–257. The authors review psychological contributions to anhedonia and related negative symptoms from a cognitive perspective and discuss the role of cognitive-behavioral therapy in the treatment of these symptoms.PubMedGoogle Scholar
- 21.Gard DE, Germans Gard M, Kring AM, et al.: Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Pers 2006, In press. The authors discuss the distinction between anticipatory and consummatory anhedonia and describe initial validation studies of a new scale they have designed to measure these constructs. Given increasing interest in this important distinction, the scale is likely to be widely used.Google Scholar
- 22.Gard DE, Kring AM, Germans MK, et al.: Emotion in the daily life of patients with schizophrenia. Poster presented at Annual Meeting of the Society for Research in Psychopathology. Boulder, CO; November 30–December 3, 2000.Google Scholar
- 24.Aghevli MA, Blanchard JJ, Horan WP: The expression and experience of emotion in schizophrenia: a study of social interactions. Psychiatry Res 2003, 119:261–270. A study using affiliative and assertive role plays in a laboratory setting. Extends evidence of abnormal affect but intact subjective emotion to the social realm, in which traditional views would predict patients with schizophrenia would experience the greatest anhedonia.PubMedCrossRefGoogle Scholar
- 44.Juckel G, Schlagenhauf F, Koslowski M, et al.: Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006, 29:409–416. A functional MRI study of neural activity during reward processing in schizophrenia. Together with the positron emission tomography study in Taylor et al. , this provides the first functional neuroimaging evidence that clearly connects reduced activity in the mesolimbic dopamine system to negative symptoms in schizophrenia.PubMedCrossRefGoogle Scholar